Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
American Journal of Cancer Research|July 10, 2023
High PIVKA-II level and ASAP score predict 1-year risk of hepatocellular carcinoma in non-cirrhotic chronic hepatitis B patientsYi-Cheng Lu, Tung-Hung Su, Tai-Chung Tseng, et al.
British Journal of Cancer|March 25, 2025
Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trialYu-Yun Shao, Ching-Tso Chen, Chien-Huai Chuang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 15, 2013
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneouslyHuei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 25, 2015
Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without CirrhosisHwai-I Yang, Tai-Chung Tseng, Jessica Liu, et al.
The Journal of Infectious Diseases|January 5, 2018
Distinct Relapse Rates and Risk Predictors After Discontinuing Tenofovir and Entecavir TherapyTung-Hung Su, Hung-Chih Yang, Tai-Chung Tseng, et al.
Journal of Gastroenterology and Hepatology|September 20, 2012
Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavirChia-Chi Wang, Kuo-Chih Tseng, Cheng-Yuan Peng, et al.
Hepatology International|March 20, 2015
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infectionHuei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, et al.
Journal of Gastroenterology and Hepatology|July 10, 2024
Serum Mac-2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virusYu-Ping Chang, Chen-Hua Liu, Chiuan-Bo Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 10, 2013
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patientsCheng-Yuan Peng, Tsung-Cheng Hsieh, Tsai-Yuan Hsieh, et al.
Journal of Viral Hepatitis|January 26, 2020
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairmentChen-Hua Liu, Sheng-Shun Yang, Cheng-Yuan Peng, et al.
Pageof 20